Amorphous oxide film on stainless steel for cardiovascular applications

C. C. Shih, C. M. Shih, Y. Y. Su, S. J. Lin

Research output: Chapter in Book/Report/Conference proceedingConference contribution

2 Citations (Scopus)

Abstract

Surface oxide film could be the most critical factor that determines the biocompatibility for the metallic cardiovascular devices. Properties of oxide films found on the marketed stents were studied by a combination of electrochemical approaches and spectroscopy: electrochemical properties using cyclic polarization, open-circuit potential and current density at open-circuit potential, and electrochemical impedance spectroscopy (EIS); oxide particle sizes and structures by transmission electron microscopy (TEM); surface morphologies by scanning electron microscopy (SEM), chemical bonding by electron spectroscopy for chemical analysis (ESCA), and lastly, the elemental depth profile by auger electron spectroscopy (AES). Degree of thrombosis was determined from the weight difference before and after 4-days in-vivo experiment. Degree of restenosis was judged from the intima/media ratio of stented iliac artery after a 28-day and a 56-day implantations in New Zealand white rabbits. Efficiency of drug elution from the amorphous oxide was detected by cyclic voltammetry, HPLC, and ESCA. Experimental evidences show that stainless steel passivated with amorphous oxide film has the oxide particle in the range of nanoscale. This amorphous oxide film displays the following characteristics: a higher time constant, a lower open-circuit potential, negative current density at open-circuit potential, a lower degree of thrombosis, minimum inflammation after stent deployment, and a ∼60% reduction of restenosis compared to currently marketed bare stents. Furthermore, it can serve effectively as the platform for drug elution without the complication of polymer coating. Taken together, these distinguishing characteristics make amorphous oxide film a stellar feature for metallic cardiovascular devices.

Original languageEnglish
Title of host publicationTransactions - 7th World Biomaterials Congress
Pages530
Number of pages1
Publication statusPublished - 2004
EventTransactions - 7th World Biomaterials Congress - Sydney, Australia
Duration: May 17 2004May 21 2004

Other

OtherTransactions - 7th World Biomaterials Congress
CountryAustralia
CitySydney
Period5/17/045/21/04

Fingerprint

Amorphous films
Oxide films
Stainless steel
Stents
Electron spectroscopy
Networks (circuits)
Oxides
Current density
Auger electron spectroscopy
Chemical analysis
Electrochemical impedance spectroscopy
Electrochemical properties
Biocompatibility
Cyclic voltammetry
Surface morphology
Particle size
Spectroscopy
Polarization
Transmission electron microscopy
Coatings

ASJC Scopus subject areas

  • Engineering(all)

Cite this

Shih, C. C., Shih, C. M., Su, Y. Y., & Lin, S. J. (2004). Amorphous oxide film on stainless steel for cardiovascular applications. In Transactions - 7th World Biomaterials Congress (pp. 530)

Amorphous oxide film on stainless steel for cardiovascular applications. / Shih, C. C.; Shih, C. M.; Su, Y. Y.; Lin, S. J.

Transactions - 7th World Biomaterials Congress. 2004. p. 530.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Shih, CC, Shih, CM, Su, YY & Lin, SJ 2004, Amorphous oxide film on stainless steel for cardiovascular applications. in Transactions - 7th World Biomaterials Congress. pp. 530, Transactions - 7th World Biomaterials Congress, Sydney, Australia, 5/17/04.
Shih CC, Shih CM, Su YY, Lin SJ. Amorphous oxide film on stainless steel for cardiovascular applications. In Transactions - 7th World Biomaterials Congress. 2004. p. 530
Shih, C. C. ; Shih, C. M. ; Su, Y. Y. ; Lin, S. J. / Amorphous oxide film on stainless steel for cardiovascular applications. Transactions - 7th World Biomaterials Congress. 2004. pp. 530
@inproceedings{264e8ef59c014056af87b5c4fea539bf,
title = "Amorphous oxide film on stainless steel for cardiovascular applications",
abstract = "Surface oxide film could be the most critical factor that determines the biocompatibility for the metallic cardiovascular devices. Properties of oxide films found on the marketed stents were studied by a combination of electrochemical approaches and spectroscopy: electrochemical properties using cyclic polarization, open-circuit potential and current density at open-circuit potential, and electrochemical impedance spectroscopy (EIS); oxide particle sizes and structures by transmission electron microscopy (TEM); surface morphologies by scanning electron microscopy (SEM), chemical bonding by electron spectroscopy for chemical analysis (ESCA), and lastly, the elemental depth profile by auger electron spectroscopy (AES). Degree of thrombosis was determined from the weight difference before and after 4-days in-vivo experiment. Degree of restenosis was judged from the intima/media ratio of stented iliac artery after a 28-day and a 56-day implantations in New Zealand white rabbits. Efficiency of drug elution from the amorphous oxide was detected by cyclic voltammetry, HPLC, and ESCA. Experimental evidences show that stainless steel passivated with amorphous oxide film has the oxide particle in the range of nanoscale. This amorphous oxide film displays the following characteristics: a higher time constant, a lower open-circuit potential, negative current density at open-circuit potential, a lower degree of thrombosis, minimum inflammation after stent deployment, and a ∼60{\%} reduction of restenosis compared to currently marketed bare stents. Furthermore, it can serve effectively as the platform for drug elution without the complication of polymer coating. Taken together, these distinguishing characteristics make amorphous oxide film a stellar feature for metallic cardiovascular devices.",
author = "Shih, {C. C.} and Shih, {C. M.} and Su, {Y. Y.} and Lin, {S. J.}",
year = "2004",
language = "English",
isbn = "1877040193",
pages = "530",
booktitle = "Transactions - 7th World Biomaterials Congress",

}

TY - GEN

T1 - Amorphous oxide film on stainless steel for cardiovascular applications

AU - Shih, C. C.

AU - Shih, C. M.

AU - Su, Y. Y.

AU - Lin, S. J.

PY - 2004

Y1 - 2004

N2 - Surface oxide film could be the most critical factor that determines the biocompatibility for the metallic cardiovascular devices. Properties of oxide films found on the marketed stents were studied by a combination of electrochemical approaches and spectroscopy: electrochemical properties using cyclic polarization, open-circuit potential and current density at open-circuit potential, and electrochemical impedance spectroscopy (EIS); oxide particle sizes and structures by transmission electron microscopy (TEM); surface morphologies by scanning electron microscopy (SEM), chemical bonding by electron spectroscopy for chemical analysis (ESCA), and lastly, the elemental depth profile by auger electron spectroscopy (AES). Degree of thrombosis was determined from the weight difference before and after 4-days in-vivo experiment. Degree of restenosis was judged from the intima/media ratio of stented iliac artery after a 28-day and a 56-day implantations in New Zealand white rabbits. Efficiency of drug elution from the amorphous oxide was detected by cyclic voltammetry, HPLC, and ESCA. Experimental evidences show that stainless steel passivated with amorphous oxide film has the oxide particle in the range of nanoscale. This amorphous oxide film displays the following characteristics: a higher time constant, a lower open-circuit potential, negative current density at open-circuit potential, a lower degree of thrombosis, minimum inflammation after stent deployment, and a ∼60% reduction of restenosis compared to currently marketed bare stents. Furthermore, it can serve effectively as the platform for drug elution without the complication of polymer coating. Taken together, these distinguishing characteristics make amorphous oxide film a stellar feature for metallic cardiovascular devices.

AB - Surface oxide film could be the most critical factor that determines the biocompatibility for the metallic cardiovascular devices. Properties of oxide films found on the marketed stents were studied by a combination of electrochemical approaches and spectroscopy: electrochemical properties using cyclic polarization, open-circuit potential and current density at open-circuit potential, and electrochemical impedance spectroscopy (EIS); oxide particle sizes and structures by transmission electron microscopy (TEM); surface morphologies by scanning electron microscopy (SEM), chemical bonding by electron spectroscopy for chemical analysis (ESCA), and lastly, the elemental depth profile by auger electron spectroscopy (AES). Degree of thrombosis was determined from the weight difference before and after 4-days in-vivo experiment. Degree of restenosis was judged from the intima/media ratio of stented iliac artery after a 28-day and a 56-day implantations in New Zealand white rabbits. Efficiency of drug elution from the amorphous oxide was detected by cyclic voltammetry, HPLC, and ESCA. Experimental evidences show that stainless steel passivated with amorphous oxide film has the oxide particle in the range of nanoscale. This amorphous oxide film displays the following characteristics: a higher time constant, a lower open-circuit potential, negative current density at open-circuit potential, a lower degree of thrombosis, minimum inflammation after stent deployment, and a ∼60% reduction of restenosis compared to currently marketed bare stents. Furthermore, it can serve effectively as the platform for drug elution without the complication of polymer coating. Taken together, these distinguishing characteristics make amorphous oxide film a stellar feature for metallic cardiovascular devices.

UR - http://www.scopus.com/inward/record.url?scp=13844272516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13844272516&partnerID=8YFLogxK

M3 - Conference contribution

AN - SCOPUS:13844272516

SN - 1877040193

SN - 9781877040191

SP - 530

BT - Transactions - 7th World Biomaterials Congress

ER -